$NVCR 4/A SEC Filings

Filed On	Filing
03 Mar 2025	Form 4/A: Weinberg Uri, Chief Innovation Officer Sold 4,637 shares ($86.9K)
03 Mar 2025	Form 4/A: Cordova Ashley, Chief Executive Officer Sold 11,153 shares ($223K) · Sold 2,341 shares ($42.8K)
03 Mar 2025	Form 4/A: Leonard Frank X, EVP, Pres., Novocure Oncology Sold 12,266 shares ($246K) · Sold 2,770 shares ($50.6K)
03 Mar 2025	Form 4/A: Puri Michal Nath, Chief Human Resources Officer Sold 1,387 shares ($27.8K)
03 Mar 2025	Form 4/A: Leupin Nicolas, Chief Medical Officer Sold 991 shares ($19.8K)
03 Mar 2025	Form 4/A: Paravasthu Mukund, Chief Operating Officer Sold 1,646 shares ($33K) · Sold 368 shares ($6.73K)
17 May 2023	Form 4/A: Stafford Kristin, Director Granted 15,873 Stock Option (Right to Buy)
13 Sep 2022	Form 4/A: Leonard Frank X, Chief Development Officer Sold 6,754 shares ($550K)
09 Apr 2021	Form 4/A: Weinberg Uri, Chief Science Officer Sold 2,835 shares ($397K)
11 Sep 2020	Form 4/A: Shah Pritesh, Chief Commercial Officer Sold 4,200 shares ($357K)
21 Feb 2017	Form 4/A: Doyle William F, Director and 1 other Holds 18,923,393 shares of Ordinary Shares

Comments